A comprehensive summary of a clinical study’s key findings, encompassing participant flow, baseline characteristics, outcome measurements, and a detailed account of adverse events, published in the ClinicalTrials.gov results database.

Source

Serious adverse eventEarly Phase 1 (formerly listed as Phase 0)